Cannabis News and Information

Global Go Consulting Cannabis Blog

Global GO 8/24/21 Global GO 8/24/21

Free Webinar: The Ultimate Global Cannabis Playbook

Global GO 8/12/21 Global GO 8/12/21

California and New Jersey Cannabis Updates

Global GO 8/9/21 Global GO 8/9/21

From: Why 3 illicit marijuana operators decline to go legal in California

Why 3 illicit marijuana operators decline to go legal in California

Global GO 8/5/21 Global GO 8/5/21

Cannabis Law And Markets: How Taxes And Regulations Impact Sales

Growth is inevitable in legal cannabis markets, as a worldwide $200-billion legacy market moves regulated channels. But results will vary as regulators in each new market experiment to find the right formula for free and legal – but taxed and licensed – markets.

Global GO 7/28/21 Global GO 7/28/21

Watch: Global Go Analytics' Tom Adams On Cannabis Markets, Investing

Benzinga’s Cannabis Insider is a live show for cannabis investors.

On Tuesday’s show, hosts Patrick Lane and Javier Hasse invited Tom Adams, CEO and principal analyst at Global Go Analytics.

https://finance.yahoo.com/news/watch-global-analytics-tom-adams-143014988.html

Global GO 7/20/21 Global GO 7/20/21

FTI Consulting/Global Go Annual Report on Cannabis Law & Markets

Act now to obtain your copy of the 1st edition of “FTI Consulting/Global Go Annual Report on Cannabis Law & Markets”. This definitive guide is the first of its kind to analyze cannabis regulations globally. Featuring the work of leading industry lawyers and consultants, this report provides an unprecedented market-by-market briefing on the regulatory regimes shaping cannabis markets worldwide.

Global GO 7/8/21 Global GO 7/8/21

Ohio Cannabis Updates

Qualifying Medical Conditions Expanded: The Ohio State Medical Board expanded the number of qualifying medical conditions to include patients suffering from Huntington’s disease, spasticity or severe muscle spasms, and those diagnosed with a terminal illness. Earlier this year, Ohio also included arthritis, chronic migraines, and complex regional pain syndrome. However, petitions to include autism spectrum disorder and restless leg syndrome were rejected.